PROSPERI, DAVIDE
 Distribuzione geografica
Continente #
NA - Nord America 24.297
EU - Europa 12.675
AS - Asia 9.210
SA - Sud America 1.492
AF - Africa 184
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 15
Totale 47.894
Nazione #
US - Stati Uniti d'America 23.690
SG - Singapore 3.370
IT - Italia 3.312
DE - Germania 2.609
CN - Cina 2.239
RU - Federazione Russa 1.296
HK - Hong Kong 1.206
BR - Brasile 1.197
VN - Vietnam 1.173
SE - Svezia 1.042
DK - Danimarca 912
IE - Irlanda 882
GB - Regno Unito 596
UA - Ucraina 523
CA - Canada 459
PL - Polonia 350
IN - India 311
FR - Francia 279
FI - Finlandia 264
AT - Austria 225
KR - Corea 189
ID - Indonesia 149
AR - Argentina 120
MX - Messico 110
TR - Turchia 88
NL - Olanda 86
JP - Giappone 82
BD - Bangladesh 71
ES - Italia 70
ZA - Sudafrica 62
EC - Ecuador 48
IQ - Iraq 45
PK - Pakistan 44
IR - Iran 40
CH - Svizzera 38
BE - Belgio 35
CZ - Repubblica Ceca 34
CO - Colombia 30
VE - Venezuela 28
SA - Arabia Saudita 26
UZ - Uzbekistan 23
KE - Kenya 22
MA - Marocco 22
IL - Israele 21
CL - Cile 20
PY - Paraguay 20
EG - Egitto 18
EU - Europa 17
GR - Grecia 16
AE - Emirati Arabi Uniti 15
AZ - Azerbaigian 15
LT - Lituania 15
RO - Romania 12
TW - Taiwan 12
UY - Uruguay 12
PE - Perù 11
AU - Australia 10
JO - Giordania 10
PH - Filippine 10
PT - Portogallo 10
JM - Giamaica 9
NO - Norvegia 9
AL - Albania 8
DO - Repubblica Dominicana 8
HU - Ungheria 8
MU - Mauritius 8
TN - Tunisia 8
BG - Bulgaria 7
BY - Bielorussia 7
KG - Kirghizistan 7
MO - Macao, regione amministrativa speciale della Cina 7
NG - Nigeria 7
CR - Costa Rica 6
DZ - Algeria 6
LB - Libano 6
MY - Malesia 6
SC - Seychelles 6
CI - Costa d'Avorio 5
GA - Gabon 5
LU - Lussemburgo 5
LV - Lettonia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
OM - Oman 5
PA - Panama 5
TH - Thailandia 5
EE - Estonia 4
ET - Etiopia 4
GE - Georgia 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NP - Nepal 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
HN - Honduras 3
QA - Qatar 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
Totale 47.858
Città #
Ann Arbor 7.834
Frankfurt am Main 2.187
Singapore 1.892
Ashburn 1.598
Woodbridge 1.587
Fairfield 1.435
Hong Kong 1.197
Milan 1.186
Chandler 1.081
Houston 1.025
Dublin 849
Wilmington 840
Seattle 550
Jacksonville 547
Dearborn 514
Cambridge 483
New York 464
Santa Clara 457
Dallas 343
Beijing 339
Los Angeles 318
Hefei 291
Princeton 290
San Jose 290
Kraków 264
Ho Chi Minh City 250
Hanoi 204
Nanjing 193
Vienna 191
Shanghai 186
Dong Ket 185
Lawrence 144
Altamura 136
Chicago 133
Seoul 132
The Dalles 131
Toronto 131
Buffalo 124
São Paulo 116
Jakarta 113
Guangzhou 112
Council Bluffs 109
Munich 106
Helsinki 90
Moscow 88
San Diego 88
Fremont 85
Lachine 85
Montréal 77
Brooklyn 74
London 71
Warsaw 69
Tokyo 66
Rome 59
Nanchang 57
Montreal 55
Turku 55
Kent 54
Ottawa 51
Orem 49
Changsha 48
Florence 48
Nuremberg 48
Shenyang 46
Pavia 43
Tianjin 43
Chennai 42
Denver 40
Salt Lake City 39
Boardman 38
Turin 38
Phoenix 37
Stockholm 37
Monza 35
Poplar 35
Hebei 34
Pune 34
Rio de Janeiro 34
Haiphong 32
Da Nang 31
Belo Horizonte 30
Brussels 30
Mexico City 30
Jinan 29
Desio 28
Palermo 28
Columbus 27
Hyderabad 27
Johannesburg 27
Old Bridge 27
Kunming 26
Atlanta 25
Boston 25
Como 25
Hangzhou 25
Jiaxing 25
Sacramento 25
Andover 24
Mumbai 24
Elk Grove Village 23
Totale 33.042
Nome #
MnO Nanoparticles Embedded in Functional Polymers as T1 Contrast Agents for Magnetic Resonance Imaging 609
H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies 594
Thirty years of cancer nanomedicine: Success, frustration, and hope 585
Inositol 1,4,5-trisphosphate 3-kinase B promotes Ca2+mobilization and the inflammatory activity of dendritic cells 585
Killing cancer cells by targeting the tumor microenvironment: study of TRAIL journey in a CAFs model 575
Engineered Ferritin Nanoparticles for the Bioluminescence Tracking of Nanodrug Delivery in Cancer 571
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 548
The emerging role of nanotechnology in skincare 547
Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems 543
Multifunctional Magnetic Gold Nanomaterials for Cancer 538
Are nanotechnological approaches the future of treating inflammatory diseases? 513
Targeted delivery of nanoparticles 511
Functionalization of colloidal nanoparticles with a discrete number of ligands based on a “HALO-bioclick” reaction 505
Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells 504
Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations 502
99mTc-radiolabeled silica nanocarriers for targeted detection and treatment of HER2-positive breast cancer 497
H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells 496
Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia 492
Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax 482
Development of99mtc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer 472
Nanoparticle-Mediated Suicide Gene Therapy for Triple Negative Breast Cancer Treatment 463
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 463
Monitoring the fate of orally administered plga nanoformulation for local delivery of therapeutic drugs 456
Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles 440
Relaxometric studies of Gd-Chelate conjugated on the surface of differently shaped gold nanoparticles 432
Dynamic molecular exchange and conformational transitions of alpha-synuclein at the nano-bio interface 425
Cetuximab-conjugates nanoparticles for the treatment of triple negative breast cancer 423
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 421
Bioengineered Approaches for Site Orientation of Peptide-Based Ligands of Nanomaterials 412
Evaluation of tfr-1 expression in feline mammary cancer and in vitro antitumor efficacy study of doxorubicin-loaded h-ferritin nanocages 406
Specific immunosuppressive role of nanodrugs targeting calcineurin in innate myeloid cells 395
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study 393
“Blind” targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates 392
A fast and straightforward procedure for vault nanoparticle purification and the characterization of its endocytic uptake 392
Metronomic nanocaged doxorubicin prevents chemoresistance and cardiotoxicity in breast cancer 387
Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies 383
Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer 380
Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide-Y Receptor 376
Anti-madcam-1-conjugated nanocarriers delivering quantum dots enable specific imaging of inflammatory bowel disease 374
Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity 370
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model 367
Half-Chain trastuzumab nanoconjugates enhance antitumor activity in HER2+ breast cancer 365
Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells 360
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages 355
Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity 352
Olaparib nanoformulation in H-Ferritin for the triple negative breast cancer treatment 351
H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer 350
Preface frontiers in cancer immunotherapy: Understanding the role of gut microbiota 346
Recent advances in magnetic fluid hyperthermia for cancer therapy 344
Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts 342
Suicide gene therapy: A new frontier for cancer fighting 328
Conformational properties of intrinsically disordered proteins bound to the surface of silica nanoparticles 327
Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice 325
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents 318
Curcumin Formulations and Trials: What’s New in Neurological Diseases 315
Development of an Effective Tumor-Targeted Contrast Agent for Magnetic Resonance Imaging Based on Mn/H-Ferritin Nanocomplexes 314
Conjugation of gold nanoparticles with multidentate surfactants for enhanced stability and biological properties 313
Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective 312
Saporin Toxin Delivered by Engineered Colloidal Nanoparticles Is Strongly Effective against Cancer Cells 311
Loss of exosomes in progranulin-associated frontotemporal dementia 310
Nano-targeting of Mucosal Addressin Cell Adhesion Molecule-1 identifies bowel inflammation foci in murine model 308
Iron oxide nanoparticles surface coating and cell uptake affect biocompatibility and inflammatory responses of endothelial cells and macrophages 300
Dependence of nanoparticle-cell recognition efficiency from surface orientation of scFv targeting ligands 299
Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands 299
Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates 296
Surfactant protein D (SP-D) as a biomarker of SARS-CoV-2 infection 294
Meet our editor-in-chief 294
Combined mass quantitation and phenotyping of intact extracellular vesicles by a microarray platform 292
Single-domain protein A-engineered magnetic nanoparticles: toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells 289
O6-alkylguanine-DNA transferase (SNAP) as capture module for site-specific covalent bioconjugation of targeting protein on nanoparticles 288
Orientation-controlled conjugation of haloalkane dehalogenase fused homing peptides to multifunctional nanoparticles for the specific recognition of cancer cells 287
MAdCAM-1 nanotargeting uncovers bowel inflammation foci in experimental model of colitis 286
Nanoparticle-mediated delivery of suicide genes in cancer therapy 283
Detection of nanostructures in solutions of Zincum metallicum and the vehicle lactose 282
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches 275
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction 270
Site-Specific Conjugation of ScFvs Antibodies to Nanoparticles by Bioorthogonal Strain-Promoted Alkyne-Nitrone Cycloaddition 269
Stem Cell-Mediated Exon Skipping of the Dystrophin Gene by the Bystander Effect 262
Antiproliferative effect of ASC-J9 delivered by PLGA nanoparticles against estrogen-dependent breast cancer cells 258
Immobilization of carboxypeptidase from Sulfolobus solfataricus on magnetic nanoparticles improves enzyme stability and functionality in organic media 258
Protein-Assisted One-Pot Synthesis and Biofunctionalization of Spherical Gold Nanoparticles for Selective Targeting of Cancer Cells 256
Click Chemistry Immobilization of Antibodies on Polymer Coated Gold Nanoparticles 255
Gold nanoparticles decorated by clustered multivalent cone-glycocalixarenes actively improve the targeting efficiency toward cancer cells 254
Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases 251
Light scattered by model phantom bacteria reveals molecular interactions at their surface 249
Towards ideal magnetofluorescent nanoparticles for bimodal detection of breast-cancer cells 249
Development of U11-functionalized gold nanoparticles for selective targeting of urokinase plasminogen activator receptor-positive breast cancer cells 248
Intracellular Drug Release from Curcumin-Loaded PLGA Nanoparticles Induces G2/M Block in Breast Cancer Cells 247
Eco-luxury: Making sustainable drugs and cosmetics with Prosopis cineraria natural extracts 243
Co-processed materials testing as excipients to produce Orally Disintegrating Tablets (ODT) using binder jet 3D-printing technology 241
A combinatorial approach to 2,4,6-trisubstituted triazines with potent antimalarial activity: combining conventional synthesis and microwave-assistance 241
Impact of semi-solid formulations on skin penetration of iron oxide nanoparticles 240
Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates to Overcome Cancer Resistance 240
Gold nanocages for imaging and therapy of prostate cancer cells 238
The synthesis of allolactose from amygdalin 235
Biotechnological approaches toward nanoparticle biofunctionalization 235
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells 235
Multi-spot, label-free biodetection at a phantom plastic-water interface 231
Towards a universal method for the stable and clean functionalization of inert perfluoropolymer nanoparticles: exploiting photopolymerizable amphiphilic diacetylenes 230
Microfluidic nanoparticle synthesis for oral solid dosage forms: A step toward clinical transition processes 226
Totale 36.090
Categoria #
all - tutte 138.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.991 0 0 0 0 0 0 578 686 600 780 499 848
2021/20225.546 605 587 601 526 334 352 451 410 317 355 390 618
2022/20235.893 745 1.452 720 619 524 793 127 210 372 102 138 91
2023/20242.895 123 86 161 131 350 624 655 96 172 76 82 339
2024/20257.258 371 601 677 364 633 308 484 298 745 1.072 647 1.058
2025/20269.693 2.024 1.015 1.220 1.811 2.040 973 610 0 0 0 0 0
Totale 49.102